Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Coronavirus: what we know from Professor Raoult's second study, which again concludes that chloroquine is effective against Covid-19
The highly publi...
Read More
France’s Secretary of State for Gender Equality, Marlène Schiappa,
has announced "temporary contact points" in shopping centers for victims of domes...
Read More
The president (LR) of the Hauts-de-Seine departmental council Patrick Devedjian has died from the coronavirus. Devedjian was under observation after b...
Read More
French President Emmanuel Macron has insisted Europe must help Italy in the face of the Covid-19 pandemic as he reiterated his support for budget soli...
Read More
The mayor of Sanary-sur-mer in the Var has introduced increased security measures during the lockdown period....
Read More
